Remember Moderna? It is one of the United States government preferred companies that made big money off the vehement push for virtually every person in America to take their experimental coronavirus “vaccine” shots promoted under the deceptive description of “safe and effective.”
Tag: FDA
New developments at the United States Food and Drug Administration (FDA) suggest that the end of giving coronavirus “vaccine” shots to children may come soon in America.
This is not the kind of news many supporters of the placement of Robert F. Kennedy, Jr. in charge of the United States Department of Health and Human Services (HHS) wanted to see come out of the Food and Drug Administration (FDA) now under his purview. Reuters reported Thursday that the FDA had given full approval — an upgrade from the previous emergency use authorization — for a new version of the mRNA coronavirus “vaccine” of drug company Moderna for children from the age of six months to 11 years old who are identified as at increased risk from coronavirus.
Categories
Vaping Madness at the FDA
“For the children.” That is a go-to justification for politicians and bureaucrats seeking to infringe on individual rights. It was on display last week in the final minutes of the testimony of Food and Drug Administration (FDA) Commissioner Marty Makary before a subcommittee of the Senate Appropriations Committee. Makary was exaggerating the extent of vaping among high school students and saying that the addiction to vaping among “kids in America” is “something that we have to address” and a “top priority” for Donald Trump’s presidential administration.
The first Donald Trump administration ushered in an American coronavirus crackdown that included among its putrid components “warp speed” production and distribution of experimental coronavirus “vaccine” shots, Those shots, though repeatedly touted by people in government and media as “safe and effective,” turned out to be both dangerous and ineffective. Now, Trump’s second administration appears to be taking another go-around with the dastardly project, with experimental mRNA shots again playing a major role. This time the excuse is bird flu.
Last week, the United States Food and Drug Administration (FDA) revoked the Emergency Use Authorization for Johnson & Johnson coronavirus shots. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, noted in a Thursday letter that the FDA made the revocation at the request of Janssen Biotech, a Johnson & Johnson subsidiary, that had related that the company would not be updating its shots, the latest “lots” purchased by the US government have expired, and “there is no demand for new lots.”
On Thursday, the Food and Drug Administration (FDA) further restricted the use of Johnson & Johnson coronavirus shots, again pushing Americans to use just the coronavirus shots from Pfizer-BioNTech and Moderna.
Yet again. The United States government’s Food and Drug Administration (FDA) this week warned of a danger — this time the bleeding disorder immune thrombocytopenia — from Johnson & Johnson’s experimental coronavirus vaccine shot, while, as usual, remaining silent about dangers from competing shots from Moderna and Pfizer-BioNTech.
Children have virtually no risk of major sickness or death from coronavirus. And experimental coronavirus “vaccines” such as the one produced by the Pfizer and BioNTech do come with major known health risks of their own. Additional potential side effects of these companies’ and other companies’ shots remain unknown given the shots’ unusually rushed rollout.
Nevertheless, on Thursday, Pfizer and BioNTech sought approval from the United States Food and Drug Administration (FDA) for giving their experimental coronavirus vaccine, which is not even a vaccine under the normal meaning of the term, to children ages five through 11. (Approval is already in place for ages 12 and up.) With the Biden administration, from Joe Biden on down, pushing for everyone — including younger children as soon as legally allowed — to receive experimental coronavirus vaccine shots, there will be much pressure on people in the FDA to give an OK to Pfizer and BioNTech’s request.
It does not seem fair. This week, Johnson & Johnson was called out by the Food and Drug Administration (FDA) for problems with Johnson & Johnson’s experimental coronavirus vaccine. While experimental coronavirus vaccine competitors Moderna and Pfizer-BioNTech skated by without censure despite their shots appearing likely to cause the same problems, the FDA put out a warning regarding the Johnson & Johnson shot.